芦可替尼乳膏(Opzelura)2022价格,用一年多少钱？

Ruxolitinib cream (Opzelura) has not yet been launched in China. The price of the product sold overseas is about 3,000 US dollars. The annual cost is relatively high. According to the recommended usage and dosage in the instructions, no more than 3 bottles a month, 12 months a year, which is about 108,000 US dollars a year. Today we will learn more about the price of ruxolitinib cream (Opzelura) in 2022. How much does it cost for one year?

Ruxolitinib Cream (Opzelura) Price in 2022

Ruxolitinib cream (Opzelura) was approved by the U.S. Food and Drug Administration for the short-term and non-continuous long-term treatment of patients 12 years and older with mild to moderate atopic dermatitis (AD) on September 21, 2021, and was again approved by the U.S. FDA on July 18, 2022 for the topical treatment of adults and pediatric patients 12 years and older with non-segmental vitiligo. At present, ruxolitinib cream (Opzelura) is not available in China, and patients need to go abroad to purchase it. In 2022, the cost of a 60g product abroad will be about US$3,000. Affected by exchange rate fluctuations, the price is not fixed.

How much does ruxolitinib cream (Opzelura) cost for one year?

Usually, the dosage of ruxolitinib cream (Opzelura) does not exceed 60g per week. The specification of this product is 60g. If you calculate 3 tubes a month, it will cost about US$108,000 a year. Patients in need can obtain the overseas marketed ruxolitinib cream (Opzelura) through domestic professional overseas medical service institutions. It can be directly mailed to their homes. It is guaranteed to be authentic and affordable, and is suitable for long-term medication for patients. For more details, please consult customer service.

Ruxolitinib cream (Opzelura) inhibits JAK1 and JAK2, which mediate the signaling of many cytokines and growth factors important for hematopoietic and immune function. Ruxolitinib cream (Opzelura) modulates the JAK-STAT pathway, a key feature of atopic dermatitis, resulting in pruritus, inflammation, and skin barrier dysfunction. It is recommended that patients take medication under the guidance of a doctor and receive symptomatic treatment.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: